Adrenal disease

Pharmacokinetics of inhaled prednisolone for adrenal crisis: an exploratory study

Eur J EndocrinolPublished Pharmacokinetic study

Authors' conclusion

The results of this study, particularly the short time to the target plasma concentration, indicate that prednisolone sodium succinate is rapidly absorbed via the lungs and that the pharmacokinetics of inhaled nebulized prednisolone sodium succinate are suitable for the outpatient treatment of adrenal crisis.

Study context

Population
Healthy participants aged 23–31 years, 50% femaleseach received both doses
Participants
12 participants
Comparison
Inhaled prednisolone sodium succinate 56.1 mg vs 112.2 mg prednisolone equivalent
Outcome
Time to reach target plasma concentration of 200 nmol/L
Methodological detailsexploratory, healthy volunteers, nebulizer administration, two dose levels on separate occasions
  • Exploratory
  • Healthy volunteers
  • Nebulizer administration
  • Two dose levels on separate occasions

Main finding

As reported in the abstract

Time to plasma concentration 200 nmol/L (excluding nebulization time of ≈10 minutes)

Safety

Tolerability

Pulmonary-administered prednisolone sodium succinate was well tolerated

Original publication

Pharmacokinetics of inhaled prednisolone for adrenal crisis: an exploratory study. Eur J Endocrinol. Published 4 August 2026. doi:10.1093/ejendo/lvag143

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.